ZA924445B - Orally active antiviral compounds - Google Patents

Orally active antiviral compounds

Info

Publication number
ZA924445B
ZA924445B ZA924445A ZA924445A ZA924445B ZA 924445 B ZA924445 B ZA 924445B ZA 924445 A ZA924445 A ZA 924445A ZA 924445 A ZA924445 A ZA 924445A ZA 924445 B ZA924445 B ZA 924445B
Authority
ZA
South Africa
Prior art keywords
alkyl
halogen
compounds
alkoxycarbonyl
carbons
Prior art date
Application number
ZA924445A
Other languages
English (en)
Inventor
Viyyoor M Girijavallabhan
M Girijavallabhan Viyyoor
Ashit K Ganguly
K Ganguly Ashit
Richard W Versace
W Versace Richard
Anil K Saksena
K Saksena Anil
Patrick A Pinto
A Pinto Patrick
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA924445B publication Critical patent/ZA924445B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA924445A 1991-06-19 1992-06-17 Orally active antiviral compounds ZA924445B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71745191A 1991-06-19 1991-06-19

Publications (1)

Publication Number Publication Date
ZA924445B true ZA924445B (en) 1993-02-24

Family

ID=24882086

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA924445A ZA924445B (en) 1991-06-19 1992-06-17 Orally active antiviral compounds

Country Status (23)

Country Link
US (4) US5559133A (xx)
EP (2) EP0519702A1 (xx)
JP (1) JP2625258B2 (xx)
KR (1) KR960004887B1 (xx)
AT (1) ATE182874T1 (xx)
AU (1) AU674657B2 (xx)
CA (1) CA2111854C (xx)
CZ (1) CZ279793A3 (xx)
DE (1) DE69229733T2 (xx)
ES (1) ES2134808T3 (xx)
FI (1) FI935690A0 (xx)
IE (1) IE921971A1 (xx)
IL (1) IL102241A0 (xx)
MX (1) MX9203068A (xx)
MY (1) MY107993A (xx)
NZ (1) NZ243180A (xx)
OA (1) OA09828A (xx)
PL (1) PL169699B1 (xx)
SK (1) SK144293A3 (xx)
TW (1) TW260658B (xx)
WO (1) WO1992022520A1 (xx)
YU (1) YU63392A (xx)
ZA (1) ZA924445B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134808T3 (es) * 1991-06-19 1999-10-16 Schering Corp Compuestos antivirales oralmente activos.
CA2156916A1 (en) * 1993-02-26 1994-09-01 Edward J. Rozhon Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans
AU6783698A (en) * 1997-04-10 1998-10-30 Pharmacia & Upjohn Company Polyaromatic antiviral compositions
WO2001009118A2 (en) * 1999-07-29 2001-02-08 Patrick T Prendergast Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2418571A1 (de) * 1973-04-18 1974-11-14 Ciba Geigy Ag Phenyl-aralkyl-aether, diphenyle und benzophenone, verfahren zu ihrer herstellung und ihre verwendung
JPS509785A (xx) * 1973-05-31 1975-01-31
JPS5922697B2 (ja) * 1976-01-13 1984-05-28 エーザイ株式会社 ビス−（メタ−アミジノフエノキシ）−化合物
DE3066406D1 (en) * 1979-09-13 1984-03-08 Wellcome Found Diaryl compounds and pharmaceutical formulations containing them
US4531009A (en) * 1982-01-29 1985-07-23 Toray Industries, Inc. Process for preparing α,ω-bis(2-chlorophenoxy)alkane-4,4'-dicarboxylic acid or its lower alkyl ester
US4851423A (en) 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
JPH0621083B2 (ja) * 1986-12-22 1994-03-23 株式会社三光開発科学研究所 ジ（アリ−ルオキシ）アルカンの製造方法
US4891449A (en) * 1988-06-30 1990-01-02 Great Lakes Chemical Corporation Halogenated unsymmetrical higher alkyl phenoxy alkanes
EP0407217A1 (en) * 1989-07-07 1991-01-09 Schering Corporation Pharmaceutically active compounds
ES2134808T3 (es) * 1991-06-19 1999-10-16 Schering Corp Compuestos antivirales oralmente activos.

Also Published As

Publication number Publication date
SK144293A3 (en) 1994-06-08
US5618849A (en) 1997-04-08
CA2111854C (en) 2001-01-09
IL102241A0 (en) 1993-01-14
YU63392A (sh) 1994-11-15
MX9203068A (es) 1993-07-01
TW260658B (xx) 1995-10-21
JPH06503839A (ja) 1994-04-28
CA2111854A1 (en) 1992-12-23
PL169699B1 (en) 1996-08-30
DE69229733D1 (de) 1999-09-09
AU674657B2 (en) 1997-01-09
US5350772A (en) 1994-09-27
JP2625258B2 (ja) 1997-07-02
ATE182874T1 (de) 1999-08-15
US5449782A (en) 1995-09-12
DE69229733T2 (de) 1999-12-02
FI935690A (fi) 1993-12-17
FI935690A0 (fi) 1993-12-17
NZ243180A (en) 1995-08-28
KR960004887B1 (ko) 1996-04-16
US5559133A (en) 1996-09-24
ES2134808T3 (es) 1999-10-16
IE921971A1 (en) 1992-12-30
AU2221392A (en) 1993-01-12
EP0519702A1 (en) 1992-12-23
CZ279793A3 (en) 1994-05-18
EP0590026A1 (en) 1994-04-06
OA09828A (en) 1994-04-15
WO1992022520A1 (en) 1992-12-23
MY107993A (en) 1996-07-15
EP0590026B1 (en) 1999-08-04

Similar Documents

Publication Publication Date Title
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
OA09334A (fr) "Dérivés d'acides aminés".
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
DK0622361T3 (da) Heterocykliske forbindelser som bradykininantagonister
WO2001009103A3 (en) Imidazole antiproliferative agents
ZA935276B (en) 3-(hydroxybenzylidenyl)-indolin-2-ones processes for their preparation and pharmaceutical compositions containing them
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
EP0370987A3 (en) Pyrazine derivatives as medicaments for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals
ZA924445B (en) Orally active antiviral compounds
DE3477380D1 (en) Novel benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
ZW12187A1 (en) 4-(aroylamino)piperidinebutanamide derivatives
IT1213301B (it) Composizioni per il trattamento del le sindromi da ischemia e riperfusione
IL100430A (en) Pharmaceutical compositions containing 2-phenyl- (ethyl or propyl)-2- (imidazol-1-yl) methyl-4- (phenylthio or phenoxy) methyl-1,3-dioxolane derivatives, certain such novel compounds and their preparation
FI894125A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
ES2010225A6 (es) Procedimiento de preparacion de nuevos derivados de piperazina diona-2,6.
TW275629B (xx)
DK0614887T3 (da) Indolsulfonamider som antitumormidler
IE890161L (en) 2-Amino Acetamide Derivatives